HemoSonics LLC is developing an easy to use and easy to interpret diagnostic device to rapidly identify diffuse coagulopathies in order to guide proper and evidence-based interventions. The management of diffuse coagulopathies is extremely important in military medicine as these conditions represent a significant source of combat morbidity and mortality. HemoSonics? device is based on sonorheometry, an ultrasound-based technology that can measure dynamic changes in clot stiffness during the process of coagulation and fibrinolysis. Sonorheometry does not require moving mechanical parts and utilizes a self-contained consumable cartridge with embedded lyophilized reagents. This technology has significant advantages over competing viscoelastometric devices such as TEG and ROTEM; sonorheometry is faster and more sensitive than TEG and ROTEM, it is ease to operate and to interpret, and it is robust to environmental vibrations. The overall goal of this proposal is to finalize the development of sonorheometry into a portable, rugged instrument that can be used in the expeditionary medicine environment. The focus in this Phase I application will be to complete demonstration of the feasibility of sonorheometry to rapidly measure the absolute contribution of platelets to clot stiffness using a real-time differential test.
Keywords: Sonorheometry, Hemostasis Characterization, Trauma Induced Coagulopathy, Clot Stiffness, Platelet Differential, Rapid Diagnostic
